Advertisement Particle Sciences expands cGMP Capabilities - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Particle Sciences expands cGMP Capabilities

Particle Sciences, a drug delivery CRO, has expanded its cGMP Capabilities with the addition of new coating capabilities for preparing polymer film-based drug products from liquid formulations.

Particle Sciences focuses on BCS II/III/IV molecules, biologics and potent compounds through different technologies such as emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others.

Particle Sciences formulation services director Garry Gwozdz said the company is seeing an increasing demand for thin film-based products, particularly with respect to transdermal drug-eluting patch products, and rapidly-dissolving strips.

"While we have been working in this area for some time, the acquisition of semi-automated coating equipment will allow us to screen more formulation approaches, and get our clients into the clinic faster with a commercially representative film-based product," Gwozdz added.

"Particle Sciences already had cGMP hot-melt film extrusion capability and now with the addition of coating and drying capabilities for liquid-based formulations, our clients have access to a complete array of viable and scalable film-manufacturing technologies."